FDA approves temporary heart device for patients awaiting transplant

10/19/2004 | Boston Globe (tiered subscription model), The · USA Today

The FDA has approved the first temporary artificial heart for use by patients who are waiting for a heart transplant and are considered to be at risk of dying within 30 days. The approval of the heart device, called the CardioWest Total Artificial Heart, came with caution, because while the device restores normal blood pressure and protects vital organs, the complex surgery that is required for installation poses its own risks.

View Full Article in:

Boston Globe (tiered subscription model), The · USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN